MeCure Industries Launches N10bn Commercial Paper at 21% Yield

MeCure Industries, a Nigerian pharmaceutical firm, has introduced a N10 billion commercial paper with a 21% yield, signaling investor interest in short-term funds. The company's revenue nearly doubled to N60.01 billion in the nine months ending September 30, 2025, with operating profit jumping 159% to N13.02 billion.

Analysts view the commercial paper as an attractive investment opportunity due to the high yield and MeCure's consistent revenue and profit growth. The move reflects a broader trend of Nigerian companies leveraging commercial paper to fund working capital expansion, particularly in sectors like pharmaceuticals.